Global Research at UCSF
contact info
  • Resources
    • About the Forum
    • UCSF Programs
    • Scholars Resource Center
    • Partners Abroad
    • UCSF Affiliated Organizations
  • Admin Forum
    • Health/Insurance Forum
    • Grant Management Forum
    • Connectivity Forum
    • IRB Forum
    • Budgeting Forum
    • Shipping forum
  • Interest Group
    • Alcohol and HIV Interest
    • East Africa Interest Group >
      • Kenya Forum
      • Tanzania Forum
      • Uganda Forum
    • Global Health Economics
    • Global Hospitalists
    • Global Maternal & Newborn
    • Global Nursing
    • Global Oncology
    • Global Oral Health
    • Global Pediatrics Interest
    • Global Surgery
    • Global Vision
    • India Interest Group >
      • India/Southeast Asia
    • Infectious Disease Implementation Science
    • Diagnostics
    • Disaster Response
    • Refugee Health
    • Malaria Interest
    • Young Investigators in International Research
  • Work Group
    • UCSF East Africa Scientific Meeting
    • East Africa Office
    • Global JrFaculty
    • International Research Advisory Committee
    • Travel Health & Safety
    • GHS Alumni
  • Newsletter

Paula Lum 

8/11/2013

0 Comments

 
Picture
Interactions between alcohol and the antiretroviral medications ritonavir or efavirenz.  Alcohol abuse occurs frequently in those with human immunodeficiency virus (HIV)
infection. Alcohol has been linked to poor response to HIV treatment and more rapid progression of HIV. One possible contributor to such observations is drug interactions between alcohol and antiretroviral (ARV) medications. This study examined drug interactions between antiretroviral therapies (ARTs) containing either efavirenz or ritonavir with alcohol.  Human immunodeficiency virus-infected individuals not currently receiving ARTs participated in a randomized, double-blind, placebo-controlled study in which alcohol (or placebo) was administered and followed by blood sampling for pharmacokinetics, subjective, cardiovascular, and neuropsychological responses obtained at predetermined times. Antiretroviral therapy was then initiated and alcohol (or placebo) sessions were repeated after at least 2 weeks of observed ART.

0 Comments



Leave a Reply.

    Author

    GlobalResearch at UCSF presents the broad scope of health research that is being conducted by UCSF researchers worldwide

    Archives

    October 2014
    September 2014
    August 2014
    July 2014
    June 2014
    May 2014
    April 2014
    March 2014
    February 2014
    January 2014
    December 2013
    November 2013
    October 2013
    September 2013
    August 2013
    July 2013
    June 2013
    May 2013

    Categories

    All
    HIV

    RSS Feed

UCSF Global Projects worldwide

Picture
Learn about UCSF Research across the globe.

UCSF Global Health Sciences (GHS)

Picture
UCSF Global Health Sciences
Our mothership.

Picture

Travel Health & Safety links

Picture

UCSF Global HUB

Picture
Compliance & logistics for global research

CTSI- Global Health Program

Picture
Tap into expertise at UCSF

✕